
==== Front
Arch Microbiol
Arch Microbiol
Archives of Microbiology
0302-8933
1432-072X
Springer Berlin Heidelberg Berlin/Heidelberg

39245770
4114
10.1007/s00203-024-04114-0
Original Paper
Genotypic and phenotypic characterisation of asymptomatic bacteriuria (ABU) isolates displaying bacterial interference against multi-drug resistant uropathogenic E. Coli
Kenneally Ciara
Murphy Craig P.
Sleator Roy D.
Culligan Eamonn P. eamonn.culligan@mtu.ie

https://ror.org/013xpqh61 grid.510393.d 0000 0004 9343 1765 Department of Biological Sciences, Munster Technological University, Cork, T12 P928 Bishopstown Ireland
Communicated by Dmitriy Volokhov.

9 9 2024
9 9 2024
2024
206 10 39410 4 2024
19 8 2024
22 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Escherichia coli can colonise the urogenital tract of individuals without causing symptoms of infection, in a condition referred to as asymptomatic bacteriuria (ABU). ABU isolates can protect the host against symptomatic urinary tract infections (UTIs) by bacterial interference against uropathogenic E. coli (UPEC). The aim of this study was to investigate the genotypic and phenotypic characteristics of five ABU isolates from midstream urine samples of adults. Comparative genomic and phenotypic analysis was conducted including an antibiotic resistance profile, pangenome analysis, and a putative virulence profile. Based on the genome analysis, the isolates consisted of one from phylogroup A, three from phylogroup B2, and one from phylogroup D. Two of the isolates, PUTS 58 and SK-106-1, were noted for their lack of antibiotic resistance and virulence genes compared to the prototypic ABU strain E. coli 83,972. This study provides insights into the genotypic and phenotypic profiles of uncharacterised ABU isolates, and how relevant fitness and virulence traits can impact their potential suitability for therapeutic bacterial interference.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00203-024-04114-0.

Keywords

Asymptomatic Bacteriuria
E. Coli
Urinary microbiome
Urobiome
Uropathogenic E. Coli
UTI
http://dx.doi.org/10.13039/501100022728 Munster Technological University Munster Technological UniversityOpen Access funding provided by the IReL Consortium

issue-copyright-statement© Springer-Verlag GmbH Germany, part of Springer Nature 2024
==== Body
pmcIntroduction

Currently, the standard definition of a urinary tract infection (UTI) is a bacterial infection that occurs in any part of the urinary system (Bono et al. 2022). This definition is ambiguous as it does not account for acute uncomplicated cystitis or asymptomatic bacteriuria (ABU) (Finucane 2017). ABU arises when two consecutive urine samples of the same bacterial isolate (≥ 105 CFU/ml) are identified from individuals lacking symptoms of infection (Nicolle et al. 2005). Occurrence of ≥ 105 CFU/ml bacteriuria also denotes a UTI in symptomatic individuals (Finucane 2017). Equivocal interpretations of UTIs means that the prescription of broad-spectrum antibiotics for these two conditions is common, yet often, not beneficial (Falagas et al. 2009; Gágyor et al. 2015). This relates to the previous doctrine that urine is sterile, and the presence of bacteria with or without symptoms indicates a state infection (Magistro and Stief 2019). Recent studies have disproved this theory, with the identification of a ‘core’ urinary microbiome (urobiome) that is currently the subject of considerable investigation (Ammitzbøll et al. 2021; Jones et al. 2021; Kenneally et al. 2022; Flores et al. 2023).

Uropathogenic Escherichia coli (UPEC) are a group of pathogenic strains that are attributable to conditions such as urinary incontinence, symptomatic UTIs (cystitis and pyelonephritis), and can lead to complications causing renal failure and urosepsis (Bien et al. 2012; Terlizzi et al. 2017). E. coli strains are also the main representatives associated with ABU (Dobrindt et al. 2016). Long term care facilities represent a hotspot for the presence of ABU strains, with the prevalence ranging from 25 to 50% in females and 15–40% in males, compared to incidences of 1–5% in younger cohorts (Nicolle 2016). Healthcare providers frequently struggle to differentiate ABU from urinary pathogens when individuals present with nonspecific symptoms, especially in the case of institutionalised patients (Cortes-Penfield et al. 2017). In turn, this has led to unnecessary prescription of antibiotics which has contributed to the evolution of multidrug resistant (MDR) E. coli (Cai et al. 2012, 2015). Currently, the European Association of Urology (EAU) guidelines prohibit treatment of ABU with the exception of two subgroups; pregnant woman and individuals undergoing surgical procedures involving breach of the bladder mucosa (Bonkat et al. 2020, 2022).

Only two ABU strains, E. coli 83,972 and E. coli HU2117 (Darouiche et al. 2010; Rudick et al. 2014; Packiriswamy et al. 2017; Schulz et al. 2020), are well characterised in the literature, with E. coli 83,972 being the prototypic ABU strain, colonising the bladder of an asymptomatic young girl for approximately three years (Lindberg et al. 1975; Andersson et al. 1991). An engineered derivative, E. coli HU2117, has been genetically modified with a deletion of papG as a safety measure to ensure P-fimbriae are not encoded to prevent adhesion to urothelium (Hull et al. 2002). E. coli 83,972 causes bacterial interference against UPEC and is the only ABU strain approved as a prophylactic treatment, for patients with lower urinary tract disfunction (LUTD) to prevent recurrent UTIs (rUTIs) (Bonkat et al. 2020). Bacterial interference is described as the use of low-virulence bacteria to compete against, inhibit colonisation, and prevent infection caused by disease-causing organisms (Darouiche and Hull 2012). In our previous study, E. coli 83,972 exhibited decreased efficacy compared to uncharacterised ABU isolates when testing antimicrobial activity against a bank of MDR UPEC (Kenneally et al. 2024).

Specifically, this work aimed to identify an ABU isolate of low virulence. Herein, we describe the genotypic and phenotypic characteristics of uncharacterised ABU isolates that previously displayed efficacious bacterial interference against a panel of MDR UPEC strains.

Materials and methods

In vitro characterisation

Bacterial strains and culture conditions

ABU isolates (PUTS 37, PUT 58, PUTS 59, S-07-4, and SK-106-1) were provided by Forsyth et al. (2018) and Leihof et al. (2021). Isolates from Forsyth et al. (2018) were obtained from midstream urine samples of healthy females between 18 and 40 years old. ABU isolates from Leihof et al. (2021) were obtained from midstream urine samples of individuals residing in nursing homes, ≥ 60 years of age. The ABU isolates were chosen for characterisation on the basis that they exhibited antimicrobial activity against UPEC in a previous study (Kenneally et al. 2024). E. coli ABU isolates were routinely cultured in Lysogeny Broth (LB; Neogen, Dublin, Ireland) at 37 °C for 18–24 h with continuous shaking or grown on LB agar (Neogen). All E. coli stocks were stored at − 20 °C and − 80 °C in 80% glycerol for further characterisation.

Confirmatory biochemical tests

Biochemical and morphological profiling were first conducted with the ABU isolate to confirm they were indeed E. coli. Colonies were grown on MacConkey (Thermo Fisher Scientific, Cork, Ireland) and Eosin Methylene Blue (EMB; Thermo Fisher Scientific) agar, and the appearance was analysed after Gram-staining (Thermo Fisher Scientific). Biochemical properties were assessed through oxidase (Merck, Dublin, Ireland) and catalase (Sigma-Aldrich, Wicklow, Ireland) testing.

Antibiotic susceptibility

Antibiotic susceptibility profiles of the ABU isolate were evaluated against clinically relevant antibiotics. Susceptibility profiling was conducted according to the Kirby-Bauer disk diffusion method at 37 °C for 24 h (CLSI, 2012). Overnight cultures were diluted to a 1.5 × 108 CFU/mL suspension (0.5 McFarland standard) in sterile LB broth and spread over the surface of Mueller-Hinton agar (Merck, Dublin, Ireland) to achieve a full lawn of growth. Once dried, sterile forceps were used to place antibiotic discs on top of the agar plate. Following a 24 h incubation at 37 °C, zones of inhibition were measured with a vernier callipers and analysed as defined by EUCAST (2023), referring to the Enterobacterales breakpoints. E. coli ATCC 25,922 was used as a reference strain. Disc diffusions were completed in triplicate.

Motility assay

The motility assay was conducted as per the protocol described by Roos et al. (2006), with modifications. Briefly, LB agar plates were prepared containing 0.3% w/v agar. Overnight cultures were diluted to 1.5 × 108 CFU/mL and 2 µL of the standardised E. coli cultures were stab pipetted in the centre of the agar plate before incubation at 37 °C for 24 h. Swimming motility was determined using a vernier callipers to measure the diameter from the centre of inoculation to determine the zone of migration.

Haemolytic activity

Columbia blood agar plates (Merck, Wicklow, Ireland) were used to determine the haemolytic activity of the E. coli isolates. Fresh overnights of ABU isolates were streaked onto separate Columbia blood agar plates. Haemolytic activity was visualised after 24 h incubation at 37 °C under anaerobic conditions. Streptococcus agalactiae MTU 4 was used as a positive control.

Biofilm formation

Biofilm formation was performed according to the microtiter plate method with crystal violet (O’Toole 2010; Whelan et al. 2020b). Briefly, overnight cultures of each isolate were prepared in LB and incubated at 37 °C for 16–18 h. Subsequently, cultures were standardised to a population of 1.5 × 108 CFU/mL in LB. In a 96-well microtiter plate, 2 µL of each culture was added to three wells containing 198 µL of LB broth supplemented with 1% w/v glucose. E. coli ATCC 25,922 was used as a positive control. Uninoculated LB broth supplemented with 1% w/v glucose was used as a sterility control and 200 µL was placed into three wells. Plates were incubated at 37 °C for 24 h. The plate was turned upside down and gentle tapping was performed to discard unbound bacteria. Wells were washed three times with 200 µL of sterile phosphate buffered saline (PBS; Sigma Aldrich). Afterwards, attached cells were heat fixed at 50 °C for 1 h. Subsequently, 200 µL of crystal violet (1% v/v) was added into each well and the plates were incubated for 20 min at room temperature. Excess stain was removed, and wells were washed with PBS. Plates were left to dry for 30 min. Biofilm-bound crystal violet was solubilised with 200 µl of 30% v/v glacial acetic acid and incubated at room temperature for 20 min. Biofilms were quantified at OD590 in a microtiter plate reader. ABU isolates were categorised based on their biofilm formation as described by Whelan et al. (2020) whereby the average biofilm formation for the control strain E. coli ATCC 25,922 was allocated a score of 1. ABU isolates were given a proportional score whereby a score of 0.5 equals to 50% of the control. Isolates scoring between 0.9 and 2.0 are strong biofilm formers. Scores between 0.4 and 0.9 are classified as weak biofilm formers, and less than 0.4 indicates indeterminate biofilm formers.

In silico genome analysis

Pangenome analysis

In addition to the ABU genomes sequenced through Enhanced Sequencing (both Illumina and Oxford Nanopore sequencing) by Microbes NG (Birmingham, United Kingdom) in our previous study (Kenneally et al., 2022), a further 68 complete and draft ABU and UTI E. coli genomes (Supplementary Table 1) were downloaded from GenBank as reference strains, including 66 from a study by Garretto et al. (2020). Genomes were annotated with PROKKA (v. 1.14.6) (Seemann 2014) under default parameters. Core and accessory genes within each genome were determined using Roary (v. 3.13) (Page et al. 2015). Coding sequences with 95% identity were considered as part of the core/accessory genome (Horesh et al. 2021), with a core genome being defined as genes present within at least 99% of samples (Page et al. 2015; Lynch et al. 2021). FASTTREE 2.10.1 (Price et al. 2010) was used to construct a maximum-likelihood phylogenetic tree based on the core genome alignment from Roary and iTOL (v6) (Letunic and Bork 2021) was used to visualise the resulting trees. The generated gene absence and presence table was analysed for gene co-occurrences (associations) and avoidance (dissociations) using Coinfinder (v 1.2.1) (Whelan et al. 2020b), applying the default significance threshold of 0.05 and employing a Bonferroni correction.

Genomic characterisation

Serotypes were assigned to the ABU isolates after genomes were analysed on SerotypeFinder 2.0 (Joensen et al. 2015). ABU isolates were categorised into phylogroups using EzClermont 0.7 (Waters et al. 2020). Multilocus sequence types (MLST) were determined on cgMLSTFinder 1.2 (Zhou et al. 2020). The identification of plasmid replicon sequences was performed using PlasmidFinder 2.1 with default parameters (threshold ID = 95%; maximum coverage = 60%) (Carattoli et al. 2014). Mobile elements and insertion sequences were identified using MobileElementFinder (Johansson et al. 2021). PHASTER was used to detect prophage elements (Arndt et al. 2016). Genomes were screened for fimH and fumC alleles on CHtyper 1.0 (Roer et al. 2018). Antimicrobial resistance genes were detected both in the genome files and the extracted plasmid sequences using ABRicate (v 0.9.8) (https://github.com/tseemann/abricate) employing the ResFinder (Florensa et al. 2022) and Comprehensive Antibiotic Resistance Database (CARD) (Alcock et al. 2023) databases.

Genomes were searched for virulence factors as previously described by Morales et al. (2023). The list of virulence factors, curated by Morales et al. (2023), included diarrheagenic virulence factors from the VirulenceFinder database and uropathogenic-associated virulence factors described in the literature. BLASTN (https://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to search for virulence factor sequences in each genome applying a threshold of 70% identity and 85% alignment to consider a virulence factor as present, in accordance with (Morales et al. 2023). Gene presence was visualised in Artemis (Carver et al. 2012) and manual annotation was conducted, where applicable, if genes had not previously been annotated.

Results

Phenotypic and biochemical characteristics

ABU isolates had typical E. coli biochemical characteristics (Table 1); Gram-negative, oxidase negative, and catalase positive isolates with adequate growth on EMB and MacConkey agar with lactose fermentation.

Antibiotic resistance profiles of the ABU isolates against 20 antibiotics which have been previously, or are currently, recommended as therapies for urogenital infections (Kot 2019; Bonkat et al. 2020, 2022) are presented in Fig. 1. All isolates were resistant to tetracycline, gentamicin, and amoxycillin/clavulanic acid. Isolates were sensitive to ciprofloxacin, nitrofurantoin, cefaclor, cefoxitin, cefadroxil, cefpodoxime, ceftriaxone, imipenem, and fosfomycin. S-07-4 was the most resistant ABU isolate, exhibiting resistance to six (37.5%) of the antibiotics, followed by PUTS 59 and SK-106-1 with resistance against five (31.3%) of the antibiotics. PUTS 58 and PUTS 37 were the least resistant isolates, displaying resistance to 4 (25%) antibiotics. S-07-4 appears to be a potential MDR isolate, however, further bioinformatic analysis was required to confirm this.

Motility tests on the ABU isolates revealed that E. coli PUTS 37 was non-motile, whilst E. coli PUTS 58 and PUTS 59 both showed low motility. Both E. coli S-07-4 and E. coli SK-106-1 were highly motile isolates (++), swarming the agar plates. None of the ABU isolates displayed β-haemolytic activity on the blood agar plates, appearing as either α- or γ-haemolytic (Table 1). All the ABU isolates exhibited weak biofilm formation capabilities (Table 1).

Table 1 Phenotypic characterisation of the ABU isolates

Isolate	Motility	Biofilm Formation	Haemolysis	
PUTS 37	−	Weak	α	
PUTS 58	+	Weak	γ	
PUTS 59	+	Weak	α	
S-07-4	++	Weak	α	
SK-106-1	++	Weak	γ	

Fig. 1 In vitro antibiotic susceptibility analysis of the ABU isolates PUTS 37, PUTS 58, PUTS 59, S-07-4, and SK-106-1

Pangenome analysis

Pangenome analysis was performed on 73 genomes in total: consisting of the five uncharacterised ABU isolates (PUTS 37, PUTS 58, PUTS 59, S-07-4, and SK-106-1), the ABU and UPEC reference genomes of E. coli 83,972 and E. coli CFT073, respectively. An additional 66 E. coli genome sequences were included in the pangenome analysis (Fig. 2), representing E. coli strains from the urinary tract of individuals with and without symptoms of infection (Garretto et al. 2020). The entire pangenome consisted of 18,317 genes present within one or more of the E. coli genomes. The core and accessory genomes consisted of 3149 and 15,168 genes, respectively. Overall, approximately 30% of the pangenome consists of unique genes (5455 genes) which correlates with previous research showing E. coli having an open pangenome (Rasko et al. 2008; Tantoso et al. 2022). This is also further reinforced by the identification of over 1,000 new unidentified genes, suggesting that new genes are likely to be continually detected as new E. coli sequences are analysed. No correlation was detected between the presence/absence of genes in the pangenome.

Fig. 2 Maximum-likelihood phylogenetic tree of 73 E. coli isolates from the urinary tract. The maximum likelihood tree was generated on FASTTREE using the core genome alignment and was visualised using iTOL. The five ABU isolates from this study are indicated with pink font. Phylogroups are indicated by the coloured boxes, as identified through EzClermont

Genome characterisation

Genome sequence analysis indicated that three of the ABU isolates (E. coli PUTS 37, PUTS 59, and SK-106-1) were representatives of the B2 phylogroup (Table 2). E. coli PUTS 58 belongs to phylogroup A and E. coli S-07-4 is a member of phylogroup D. MLSTs varied amongst the five ABU isolates in accordance with the cgMLST Escherichia coli database, Enterobase (Zhou et al. 2020). E. coli PUTS 37 and E. coli PUTS 59 represented the same MLST, ST95, clustered together with avian pathogenic E. coli (APEC) and UPEC isolates. E. coli PUTS 58 was grouped into ST2795, a MSLT group containing few E. coli isolates thus far. E. coli PUTS 58 is clustered together with one known enterotoxigenic E. coli (ETEC) isolate, E. coli 1743. Additional E. coli isolates grouped into ST2795 in the literature are from marine environments (Kvesić et al. 2022). E. coli SK-106-1 belonged to ST12 and E. coli S-07-4 was grouped as ST69. ST12 has previously been associated with UPEC (Nüesch-Inderbinen et al. 2017; Drage et al. 2019), meanwhile, ST69 is an MLST group associated with the ‘pandemic UPEC clones’ (Yamaji et al. 2018).

All ABU isolates were predicted to harbour at least one plasmid (Table 3). The genome sequence of E. coli PUTS 58 was found to contain the most plasmids as ten plasmid replicon sequences were detected. Similar to previous studies, colicin-encoding plasmids (Col) and incompatibility plasmids (Inc) were most abundant in the ABU isolates (Garretto et al. 2020; Morales et al. 2023). E. coli S-07-4 contained an IncQ1 plasmid which was predicted to contain the antimicrobial resistance gene blaTEM-1B. E. coli PUTS 37 was the only ABU genome with a plasmid encoding a virulence factor, an observation typically associated with the B2 phylogroup. In this instance, the iron transport locus sitA was detected on a IncFIB plasmid.

Additional mobile genetic elements were identified in all five ABU genomes with MobileElementFinder. ABUs contained ≥ 14 mobile genetic elements (MGEs). MGEs present in E. coli PUTS 59 contained the most virulence genes, with a total of 14 virulence factors encoded by various MGEs. Whilst this observation is consistent with the B2 phylogroup, the ABU isolate representing the phylogroup A, E. coli PUTS 58, contained the most MGEs (n = 28) encoding the fewest number of virulence-associated genes (n = 0). Prophage elements were found in all isolates, with enterobacterial phages the most abundant prophages identified; however, E. coli S-07-4 contained no complete sequences. E. coli PUTS 37 contained the most complete prophage elements, whilst E. coli SK-106-1 contained the least (Table 4). Thus, no correlation to the B2 phylogroup was observed.

Antimicrobial resistance gene predictions showed that every ABU isolates contains the mdfA (multidrug efflux) gene (Table 5). The phenotypic analysis did not correlate with the genotypic profile for isolate PUTS 37, PUTS 58, PUTS 59, and SK-106-1 as they were lacking in additional resistance genes. E. coli S-07-4 was the only ABU isolate analysed that contained additional resistance genes. In total, 12 resistance genes were present in the S-07-4 genome, further supporting that S-07-4 can be defined as a MDR isolate. .

Table 2 Genome-based characterisation of the ABU isolates

Isolate	Phylogroup	Serotype	Sequence type	Intact prophage	Plasmid Replicons	MGEs	
PUTS 37	B2	O2:H4	ST 95	8	2	13	
PUTS 58	A	O160:H27	ST 2795	4	10	28	
PUTS 59	B2	O18:H7	ST 95	6	3	14	
S-07-4	D	nt: H18	ST 69	0	1	14	
SK-106-1	B2	O4:H5	ST 12	1	1	14	

Table 3 Plasmid replicons identified in the ABU genomes

Isolate	Plasmid Replicons	
PUTS 37	IncFIB, IncFIC	
PUTS 58	Col440I, pENTAS02, Col440I, ColpVC, ColRNAI, IncHI1B, IncHI1A, IncN, IncFIA, Col156	
PUTS 59	IncFIB, Col156, IncFII	
S-07-4	IncQ1	
SK-106-1	IncBOKZ	

Table 4 Intact prophages identified in the ABU genomes

Isolate	Intact Prophages	
PUTS 37	Escherichia phage STX2, Escherichia phage pro483, Enterobacteria phage λ, Enterobacteria phage cdtI, Enterobacteria phage λ, Enterobacteria phage cdtI, Enterobacteria phage Sf101, Shigella phage SfII	
PUTS 58	Enterobacteria phage phiT5282H, Enterobacteria phage λ, Klebsiella phage ST512, Escherichia phage RCS47	
PUTS 59	Shigella phage SfII, Enterobacteria phage Sf101, Enterobacteria phage λ, Enterobacteria phage λ, Burkholderia phage phiE255, Escherichia phage STX2	
SK-106-1	Enterobacteria phage λ	

Table 5 Antimicrobial resistance (AMR) genes identified in the ABU isolates

AMR genes	PUTS 37	PUTS 58	PUTS 59	S-07-4	SK-106-1	
aph(6)-Id	−	−	−	+	−	
aph(3″)-Ib	−	−	−	+	−	
ant(3″)-Ia	−	−	−	+	−	
aadA1	−	−	−	+	−	
aadA5	−	−	−	+	−	
blaTEM-1B	−	−	−	+	−	
dfrA1	−	−	−	+	−	
mdf (A)	+	+	+	+	+	
mph(B)	−	−	−	+	−	
sul1	−	−	−	+	−	
sul2	−	−	−	+	−	
tet(A)	−	−	−	+	−	

The presence of virulence factors in the ABU isolates was compared to two reference genomes, the ABU strain E. coli 83,972 and the UPEC strain E. coli CFT073 (Fig. 3). E. coli PUTS 59 was most similar to E. coli 83,972, lacking only five of the virulence factors that the prototypic strain encodes. The two other members of the B2 phylogroup, E. coli PUTS 37 and E. coli SK-106-1 vastly differed in the virulence factors they encode when analysed against PUTS 59. Of particular note were virulence factors associated with iron acquisition and adhesion. Virulence factors present in PUTS 37 are similar to PUTS 59, however, eight virulence genes that were identified in PUTS 59 were not present in PUTS 37. Additionally, SK-106-1 contains nine virulence factors that were also present in PUTS 59. E. coli S-07-4 contained the least amount of virulence factors, with only five being identified in the entire genome (Table 6).

E. coli S-07-4 contained no iron acquisition genes (Table 6). Iron acquisition genes present in E. coli PUTS 58 encode the enterobactin siderophore system. PUTS 37 and PUTS 59 also contained the enterobactin siderophore genes, along with genes required for yersiniabactin production. PUTS 59 was the only ABU isolate to also encode the salmochelin siderophore uptake system. When salmochelin is encoded with colibactin and a bacteriocin, this typically can point to an E. coli isolate having the potential to become a more invasive pathogen (Massip et al. 2020). Colibactin (clb) was present only in E. coli PUTS 59. Chaperone-usher fimbriae determinants were found in every ABU isolate. Type 1 fimbriae and E. coli common pilus (ECP) genes were encoded by all five ABU isolates. P-fimbriae determinants were encoded by E. coli PUTS 59, S-07-4, and SK-106-1, whilst F1C fimbriae were not present in any of the new ABU isolates analysed in this study.

Table 6 Abundance of virulence factors in ABU isolates and their frequency on plasmids and mobile genetic elements

Isolate	Virulence factors	Adhesion	Iron acquisition	Toxins	Plasmid encoded	MGE encoded	
PUTS 37	18	7	7	1	1	6	
PUTS 58	8	4	3	0	0	0	
PUTS 59	27	9	7	4	0	14	
S-07-4	5	4	0	1	0	1	
SK-106-1	10	5	1	1	0	6	

Fig. 3 Heatmap indicating the presence or absence of virulence genes. The heatmap is based on the nucleotide percentage identity of virulence genes determined by BLASTN. Virulence genes are grouped according to function. Blue indicates the presence of a gene, yellow indicates the absence of a gene. Reference genomes included the ABU strain E. coli 83,972 and UPEC strain E. coli CFT073

Discussion

E. coli is a versatile bacterium that colonises the urogenital tract, and remains the most common organism isolated from females (Klein and Hultgren 2020; Price et al. 2020). The severity of E. coli-mediated infections depends on the virulence potential of the specific strain, together with the robustness of the host’s immune response. ABU isolates are typically associated with encoding fewer virulence factors than cystitis- or pyelonephritis-causing UPEC, and have been proposed to have a fitness advantage over pathogenic strains (Watts et al. 2010; Stork et al. 2018). Bacteria deemed suitable for use as probiotics are required to be of low-virulence and contain no antibiotic resistance genes. Our previous study highlight the antimicrobial activity of five ABU strains against UPEC (Kenneally et al. 2022).This study, therefore, aimed to phenotypically and genotypically characterise the five ABU isolates, and determine their suitability as live biotherapeutics to establish bacterial interference against UPEC. E. coli 83,972 has received much attention due to its success as a prophylactic for individuals suffering from LUTD, establishing bacterial interference (Bonkat et al. 2022). This study presents five ABU isolates with low in vitro virulence properties and which, in general, contain fewer virulence factors than E. coli 83,972.

ABU isolates typically fall into two categories; isolates that resemble commensal E. coli belong to the phylogroups A and B1 have fewer virulence genes, and ABU E. coli which resemble UPEC belong to phylogroup B2 and D (Biggel et al. 2020). Putative virulence factors are mostly found in phylogroup B2 strains, however these are not always linked to pathogenicity. Highly virulent, extensively characterised UPEC strains, CFT073 and UTI89, are B2 members (Hogins et al. 2023). E. coli 83,972 also belongs to the B2 group, however, many of the virulence factors in 83,972 are inactive due to point mutations (Klemm et al. 2007; Zdziarski et al. 2008, 2010). Four of the ABU isolates in this study appear more closely related to UPEC; PUTS 37, PUTS 59, and SK-106-1 belong to phylogroup B2 and S-07-4 to phylogroup D. The allocation of MLSTs to these isolates correlated with the phylogroups. In particular, ST95 (PUTS 37 and PUTS 59) and ST69 (S-07-4) have both been referred to as pandemic MLSTs due to high levels of multidrug resistant UPEC strains identified among these ST’s (Yamaji et al. 2018; Tarlton et al. 2019; de Souza da-Silva et al. 2020). Meanwhile, PUTS 58 appears to resemble a commensal, categorised as phylogroup A and contains fewer putative virulence factors than E. coli 83,972.

The putative avirulent nature of the investigated ABU isolates may result from the presence of dormant virulence factors. Overall, PUTS 37, PUTS 58, S-07-4, and SK-106-1 contained few adhesins compared to E. coli 83,972, while PUTS 59 more closely resembled the virulence profile. Here, fim and ecpA were the only two putative virulence factors identified in every isolate. In particular, fim genes are required to express type 1-fimbriae. Deletion and mutations of fim genes in UPEC does hinder the ability to colonise the bladder (Spaulding et al. 2017), however, the fim genes are highly conserved in commensal strains enhancing colonisation (Watts et al. 2010; Chevalier et al. 2021). The ecpA gene is also widely distributed among commensal and pathogenic strains, enhancing cell adherence and, contrary to our results, biofilm formation (Saldaña et al. 2009, 2014). Interestingly, a recent study by Naziri et al. (2021) determined that the difference between weak and strong biofilm formers often resulted in the presence of sfa genes in UPEC. PUTS 59 and SK-106-1 were the only two ABU isolates containing the sfa gene, which possibly contributed to the weak biofilm formation observed. Thus, the investigated ABU isolates appear to be of low-virulence compared to clinically relevant UPEC (Davari Abad et al. 2019; Naziri et al. 2021).

UPEC are known for having a complex virulence profile, resulting in latent reservoirs and subsequently incidence of rUTIs (Vagios et al. 2020). In contrast, ABU isolates can successfully reduce UPEC levels and establish long-term persistence due to the competition for attachment sites and nutrients (Darouiche and Hull 2012). Yersiniabactin, salmochelin, and aerobactin siderophores play a role in iron uptake, important for ABU growth in urine (Frick-Cheng et al. 2020; Massip et al. 2020). PUTS 59 contains both the salmochelin, yersiniabactin and aerobactin siderophore genes, along with enterobactin producing genes. PUTS 37 lacks the salmochelin genes and PUTS 58 contains only the aerobactin and enterobactin genes. Production of different siderophores can make a bacterium more adaptive, as siderophores are maximally produced at different pH levels and in different carbon sources (Valdebenito et al. 2006). The production of a variety of siderophores in urogenital E. coli is likely a competitive trait as urine can span a wide pH range of ~ 4.5–8.0, and contains limited carbon and iron (Reitzer and Zimmern 2020). Furthermore, siderophores can contribute increased pathogenesis causing a bacterium to invade urethral cells, disrupt the iron homeostasis of competing bacteria, and induce mitochondrial autophagy (Khasheii et al. 2021).

Of potential concern, PUTS 59 encodes colibactin, a virulence factor that appears to have a functional synergy with salmochelin; promoting colonisation, if not also enhancing virulence (Massip et al. 2020). Furthermore, PUTS 59 produces the pore-forming toxin, HlyA, which can alter epithelial cells, disable macrophages, and supress inflammatory responses, ultimately causing serious tissue damage (Dhakal and Mulvey 2012; Wang et al. 2020). PUTS 59 has the most similar virulence profile to E. coli CFT073 and 83,972. S-07-4, on the other hand, contains the fewest virulence genes, but has the most antibiotic resistance genes.

Antibiotic treatment of ABU strains is rarely beneficial, and is associated with higher rates of rUTIs and antimicrobial resistance (Cai et al. 2012, 2015). The mdfA gene was present in every ABU isolate analysed in this study. This gene encodes the MdfA multidrug efflux protein (Yardeni et al. 2020), conferring resistance to a broad spectrum of antibiotics including chloramphenicol, tetracycline, erythromycin, and fluoroquinolones (Edgar and Bibi 1997; Suarez and Martiny 2021). E. coli S-07-4 was the only isolate that harboured more than one resistance gene, containing a total of twelve. S-07-4 has the potential to be resistant to multiple drugs, including aminoglycosides, fluroquinolones, sulphonamides, tetracyclines, cephalosporins, and carbapenems (Ashenafi et al. 2014; Hansen et al. 2019; Adekanmbi et al. 2020). The in vitro antimicrobial resistance screen revealed that the ABU isolates were susceptible to first-generation cephalosporins, a first-line treatment for UTIs. However, this study only included five ABU isolates and a previous meta-analysis representing 8 countries (Poland, Iran, Jordan, Mexico, China, India, Nigeria, and Brazil) has reported resistance rates against first-generation and third-generation cephalosporins to be 38.8% and 37.0%, respectively (Bunduki et al. 2021).

Interestingly, E. coli PUTS 58 and SK-106-1 were characterised as isolates with low in vitro virulence. In silico analysis supported this, as the virulence gene profile was less than that of E. coli 83,972 and CFT073. Furthermore, both isolates contained only one antibiotic resistance gene, further suggesting PUTS 58 and SK-106-1 could be suitable biotherapeutics. PUTS 58 and SK-106-1 have previously exhibited superior interference and antimicrobial activity against UPEC strains, compared to other investigated ABU isolates and E. coli 83,972 (Kenneally et al., 2022). In particular, PUTS 58 appears to resemble commensal E. coli and the presence of both aerobactin and enterobactin siderophores may contribute to the persistence of PUTS 58 in iron-limiting environments, such as urine. Our previous studies have also indicated that PUTS 58 cell free supernatant is stable in clinically relevant conditions such pH of 2.5–10 and temperatures of 4–70 °C (Kenneally et al., 2024).

The under-utilisation of ABU isolates, to date, can be ascribed to a lack of research on their safety profile and influence on the urobiome. This study was limited to the characterisation of five ABU isolates, as our research has identified that the five ABU isolatess display antimicrobial activity against UPEC (Kenneally et al. 2024). Furthermore, the full safety profile is still warranted as a limitation of this study was that the up/down-regulation of virulence genes in real-time was not able to be conducted. This will furtheranalyse the full safety profile and unveil a more comprehensive molecular profile of the ABU isolates, in particular, PUTS 58. Additionally, in vitro cell culture and in vivo analysis in bladder models to determine if PUTS 58 is durable when attaching to catheters and successfully inhibits uropathogens is warranted, as E. coli 83,972 satisfies this criteria for LUTD patients enduring rUTIs. Ultimately, further investigations could result in ABU isolates gaining a Generally Recognised as Safe (GRAS) status and be implemented as urobiome-based therapeutics.

Supplementary Information

Below is the link to the electronic supplementary material. Supplementary material 1 (DOCX 25.2 kb)

Acknowledgements

We would like to acknowledge Valerie Forsyth (University of Michigan) and Prof Niels Frimodt-Møller (Rigshospitalet, Copenhagen) for the provision of the ABU strains. We would like to thank Shane Whelan (Munster Technological University) for proving the UPEC strains.

Author contributions

CK: Conceptualization; Project Administration; Funding Acquisition; Methodology; Data Curation; Formal Analysis; Validation; Visualization; Writing—Original Draft Preparation. CPM: Supervision; Writing—Review & Editing. RDS: Supervision; Writing—Review & Editing. EPC: Supervision; Funding Acquisition; Conceptualization; Writing—Review & Editing.

Funding

Open Access funding provided by the IReL Consortium. Ciara Kenneally is in receipt of a RISAM PhD Fellowship at Munster Technological University.

Data availability

Raw reads and assembled contigs are available under the accession numbers JBAKMN000000000, JBAKMO000000000, JBAKMP000000000, DAEBDQ000000000, DAEBEH000000000.

Declarations

Conflict of interest

The authors declare that there are no conflicts of interest regarding the publication of this paper of which we are aware.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

Adekanmbi AO Adejoba AT Banjo OA Saki M Detection of sul1 and sul2 genes in sulfonamide-resistant bacteria (SRB) from sewage, aquaculture sources, animal wastes and hospital wastewater in South-West Nigeria Gene Rep Elsevier 2020 20 June 100742 10.1016/j.genrep.2020.100742
Adekanmbi AO, Adejoba AT, Banjo OA, Saki M (2020) Detection of sul1 and sul2 genes in sulfonamide-resistant bacteria (SRB) from sewage, aquaculture sources, animal wastes and hospital wastewater in South-West Nigeria. Gene Rep Elsevier 20(June):100742. 10.1016/j.genrep.2020.10074210.1016/j.genrep.2020.100742
Alcock BP Huynh W Chalil R Smith KW Raphenya AR Wlodarski MA Edalatmand A Petkau A Syed SA Tsang KK Baker SJC Dave M Mccarthy MC Mukiri KM Nasir JA Golbon B Imtiaz H Jiang X Kaur K Kwong M Liang ZC Niu KC Shan P Yang JYJ Gray KL Hoad GR Jia B Bhando T Carfrae LA Farha MA French S Gordzevich R Rachwalski K Tu MM Bordeleau E Dooley D Griffiths E Zubyk HL Brown ED Maguire F Beiko RG Hsiao WWL Brinkman FSL Van Domselaar G Mcarthur AG CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database Nucleic Acids Res 2023 51 1D D690 D699 10.1093/nar/gkac920 36263822
Alcock BP, Huynh W, Chalil R, Smith KW, Raphenya AR, Wlodarski MA, Edalatmand A, Petkau A, Syed SA, Tsang KK, Baker SJC, Dave M, Mccarthy MC, Mukiri KM, Nasir JA, Golbon B, Imtiaz H, Jiang X, Kaur K, Kwong M, Liang ZC, Niu KC, Shan P, Yang JYJ, Gray KL, Hoad GR, Jia B, Bhando T, Carfrae LA, Farha MA, French S, Gordzevich R, Rachwalski K, Tu MM, Bordeleau E, Dooley D, Griffiths E, Zubyk HL, Brown ED, Maguire F, Beiko RG, Hsiao WWL, Brinkman FSL, Van Domselaar G, Mcarthur AG (2023) CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res 51(1D):D690–D699. 10.1093/nar/gkac92036263822 10.1093/nar/gkac920
Ammitzbøll N Bau BPJ Bundgaard-Nielsen C Villadsen AB Jensen AM Leutscher PDC Glavind K Hagstrøm S Arenholt LTS Sørensen S Pre- and postmenopausal women have different core urinary microbiota Sci Rep 2021 11 1 1 10 10.1038/s41598-021-81790-8 33414495
Ammitzbøll N, Bau BPJ, Bundgaard-Nielsen C, Villadsen AB, Jensen AM, Leutscher PDC, Glavind K, Hagstrøm S, Arenholt LTS, Sørensen S (2021) Pre- and postmenopausal women have different core urinary microbiota. Sci Rep 11(1):1–10. 10.1038/s41598-021-81790-833414495 10.1038/s41598-021-81790-8
Andersson P Engberg I Lidin-Janson G Lincoln K Hull R Hull S Svanborg C Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence Infect Immun 1991 59 9 2915 2921 10.1128/iai.59.9.2915-2921.1991 1879917
Andersson P, Engberg I, Lidin-Janson G, Lincoln K, Hull R, Hull S, Svanborg C (1991) Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun 59(9):2915–2921. 10.1128/iai.59.9.2915-2921.19911879917 10.1128/iai.59.9.2915-2921.1991
Arndt D Grant JR Marcu A Sajed T Pon A Liang Y Wishart DS PHASTER: a better, faster version of the PHAST phage search tool Nucleic Acids Res 2016 44 W1 W16 W21 10.1093/nar/gkw387 27141966
Arndt D, Grant JR, Marcu A, Sajed T, Pon A, Liang Y, Wishart DS (2016) PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res 44(W1):W16–W21. 10.1093/nar/gkw38727141966 10.1093/nar/gkw387
Ashenafi M Ammosova T Nekhai S Byrnes WM Purification and characterization of aminoglycoside phosphotransferase APH(6)-Id, a streptomycin-inactivating enzyme Mol Cell Biochem 2014 387 1–2 207 216 10.1007/s11010-013-1886-1 24248535
Ashenafi M, Ammosova T, Nekhai S, Byrnes WM (2014) Purification and characterization of aminoglycoside phosphotransferase APH(6)-Id, a streptomycin-inactivating enzyme. Mol Cell Biochem 387(1–2):207–216. 10.1007/s11010-013-1886-124248535 10.1007/s11010-013-1886-1
Bien J Sokolova O Bozko P Role of uropathogenic escherichia coli virulence factors in development of urinary tract infection and kidney damage Int J Nephrol 2012 10.1155/2012/681473 22506110
Bien J, Sokolova O, Bozko P (2012) Role of uropathogenic escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol. 10.1155/2012/68147322506110 10.1155/2012/681473
Biggel M Xavier BB Johnson JR Nielsen KL Frimodt-Møller N Matheeussen V Goossens H Moons P Van Puyvelde S Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages Nat Commun 2020 10.1038/s41467-020-19714-9 33235212
Biggel M, Xavier BB, Johnson JR, Nielsen KL, Frimodt-Møller N, Matheeussen V, Goossens H, Moons P, Van Puyvelde S (2020) Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages. Nat Commun. 10.1038/s41467-020-19714-933235212 10.1038/s41467-020-19714-9
Bonkat G Bartoletti R Bruyère F Cai T Geerlings SE Köves B Schubert S Wagenlehner F Mezei T Pilatz A Pradere B Veeratterapillay R EAU 2020 guidelines on urological infections 2020 European Association of Urology
Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Köves B, Schubert S, Wagenlehner F, Mezei T, Pilatz A, Pradere B, Veeratterapillay R (2020) EAU 2020 guidelines on urological infections. European Association of Urology. http://www.uroweb.org/gls/pdf/15_Urological_Infections.pdf
Bonkat G Cai T Galeone C Koves B Bruyere F Adherence to European Association of Urology Guidelines and State of the art of Glycosaminoglycan Therapy for the management of urinary tract infections: a Narrative Review and Expert Meeting Report Eur Urol Open Sci 2022 44 37 45 10.1016/j.euros.2022.07.009 36051173
Bonkat G, Cai T, Galeone C, Koves B, Bruyere F (2022) Adherence to European Association of Urology Guidelines and State of the art of Glycosaminoglycan Therapy for the management of urinary tract infections: a Narrative Review and Expert Meeting Report. Eur Urol Open Sci 44:37–45. 10.1016/j.euros.2022.07.00936051173 10.1016/j.euros.2022.07.009
Bono M, Leslie S, Reygaert W (2022) Urinary Tract Infection. Treasure Island (FL): StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK470195/#_ncbi_dlg_citbx_NBK470195
Bunduki GK Heinz E Phiri VS Noah P Feasey N Musaya J Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis BMC Infect Dis 2021 21 1 1 13 10.1186/s12879-021-06435-7 33390160
Bunduki GK, Heinz E, Phiri VS, Noah P, Feasey N, Musaya J (2021) Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis. BMC Infect Dis 21(1):1–13. 10.1186/s12879-021-06435-733390160 10.1186/s12879-021-06435-7
Cai T Mazzoli S Mondaini N Meacci F Nesi G D’Elia C Malossini G Boddi V Bartoletti R The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? Clin Infect Dis 2012 55 6 771 777 10.1093/cid/cis534 22677710
Cai T, Mazzoli S, Mondaini N, Meacci F, Nesi G, D’Elia C, Malossini G, Boddi V, Bartoletti R (2012) The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? Clin Infect Dis 55(6):771–777. 10.1093/cid/cis53422677710 10.1093/cid/cis534
Cai T Nesi G Mazzoli S Meacci F Lanzafame P Caciagli P Mereu L Tateo S Malossini G Selli C Bartoletti R Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections Clin Infect Dis 2015 61 11 1655 1661 10.1093/cid/civ696 26270684
Cai T, Nesi G, Mazzoli S, Meacci F, Lanzafame P, Caciagli P, Mereu L, Tateo S, Malossini G, Selli C, Bartoletti R (2015) Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections. Clin Infect Dis 61(11):1655–1661. 10.1093/cid/civ69626270684 10.1093/cid/civ696
Carattoli A Zankari E Garciá-Fernández A Larsen MV Lund O Villa L Aarestrup FM Hasman H In Silico detection and typing of plasmids using plasmidfinder and plasmid multilocus sequence typing Antimicrob Agents Chemother 2014 58 7 3895 3903 10.1128/AAC.02412-14 24777092
Carattoli A, Zankari E, Garciá-Fernández A, Larsen MV, Lund O, Villa L, Aarestrup FM, Hasman H (2014) In Silico detection and typing of plasmids using plasmidfinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 58(7):3895–3903. 10.1128/AAC.02412-1424777092 10.1128/AAC.02412-14
Carver T Harris SR Berriman M Parkhill J McQuillan JA Artemis: an Integrated Platform for Visualization and analysis of high-throughput sequence-based Experimental Data Bioinform 2012 28 4 464 469 10.1093/bioinformatics/btr703
Carver T, Harris SR, Berriman M, Parkhill J, McQuillan JA (2012) Artemis: an Integrated Platform for Visualization and analysis of high-throughput sequence-based Experimental Data. Bioinform 28(4):464–469. 10.1093/bioinformatics/btr70310.1093/bioinformatics/btr703
Chevalier G Laveissière A Desachy G Barnich N Sivignon A Maresca M Nicoletti C Di Pasquale E Martinez-Medina M Simpson KW Yajnik V Sokol H Adegbamigbe T Ahmad T Arnott I Bouhnik Y Carbonnel F Colombel JF Doherty G Cummings JRF Hébuterne X Herfarth H Kevans D de Chambrun GP Nachury M Nancey S Roblin X Tremelling MAW Plassais J Strozzi F Cervino A Morra R Bonny C Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn’s disease Microbiome 2021 9 1 1 16 10.1186/s40168-021-01135-5 33388088
Chevalier G, Laveissière A, Desachy G, Barnich N, Sivignon A, Maresca M, Nicoletti C, Di Pasquale E, Martinez-Medina M, Simpson KW, Yajnik V, Sokol H, Adegbamigbe T, Ahmad T, Arnott I, Bouhnik Y, Carbonnel F, Colombel JF, Doherty G, Cummings JRF, Hébuterne X, Herfarth H, Kevans D, de Chambrun GP, Nachury M, Nancey S, Roblin X, Tremelling MAW, Plassais J, Strozzi F, Cervino A, Morra R, Bonny C (2021) Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn’s disease. Microbiome 9(1):1–16. 10.1186/s40168-021-01135-533388088 10.1186/s40168-021-01135-5
CLSI Performance standards for antimicrobial disk susceptibility tests: approved standard Clinical and Laboratory Standards 2012 11 Detroit Wayne M02 A11
CLSI (2012) Performance standards for antimicrobial disk susceptibility tests: approved standard. Clinical and Laboratory Standards, 11th edn. Wayne, Detroit, pp M02-A11
Cortes-Penfield NW Trautner BW Jump RLP Urinary tract infection and asymptomatic Bacteriuria in older adults Infect Dis Clin North Am 2017 31 4 673 688 10.1016/j.idc.2017.07.002 29079155
Cortes-Penfield NW, Trautner BW, Jump RLP (2017) Urinary tract infection and asymptomatic Bacteriuria in older adults. Infect Dis Clin North Am 31(4):673–688. 10.1016/j.idc.2017.07.00229079155 10.1016/j.idc.2017.07.002
Darouiche RO Hull RA Bacterial Interference for Prevention of Urinary Tract Infection Clin Infect Dis 2012 55 10 1400 1407 10.1093/cid/cis639 22828592
Darouiche RO, Hull RA (2012) Bacterial Interference for Prevention of Urinary Tract Infection. Clin Infect Dis 55(10):1400–1407. 10.1093/cid/cis63922828592 10.1093/cid/cis639
Darouiche RO Riosa S Hull RA Comparison of Escherichia coli strains as agents for bacterial interference Infect Control Hosp Epidemiol 2010 31 6 659 661 10.1086/653070 20426581
Darouiche RO, Riosa S, Hull RA (2010) Comparison of Escherichia coli strains as agents for bacterial interference. Infect Control Hosp Epidemiol 31(6):659–661. 10.1086/65307020426581 10.1086/653070
Davari Abad E Khameneh A Vahedi L Identification phenotypic and genotypic characterization of biofilm formation in Escherichia coli isolated from urinary tract infections and their antibiotics resistance BMC Res Notes 2019 12 1 1 7 10.1186/s13104-019-4825-8 30602384
Davari Abad E, Khameneh A, Vahedi L (2019) Identification phenotypic and genotypic characterization of biofilm formation in Escherichia coli isolated from urinary tract infections and their antibiotics resistance. BMC Res Notes 12(1):1–7. 10.1186/s13104-019-4825-830602384 10.1186/s13104-019-4825-8
de Souza da-Silva AP de Sousa VS de Araújo Longo LG Caldera S Baltazar ICL Bonelli RR Santoro-Lopes G Riley LW Moreira BM Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio De Janeiro: impact of Escherichia coli genotypes ST69 and ST131 Infect Genet Evol 2020 85 104452 10.1016/j.meegid.2020.104452 32634601
de Souza da-Silva AP, de Sousa VS, de Araújo Longo LG, Caldera S, Baltazar ICL, Bonelli RR, Santoro-Lopes G, Riley LW, Moreira BM (2020) Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio De Janeiro: impact of Escherichia coli genotypes ST69 and ST131. Infect Genet Evol 85:104452. 10.1016/j.meegid.2020.10445232634601 10.1016/j.meegid.2020.104452
Dhakal BK Mulvey MA The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways Cell Host Microbe 2012 10.1016/j.chom.2011.12.003 22264513
Dhakal BK, Mulvey MA (2012) The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe. 10.1016/j.chom.2011.12.00322264513 10.1016/j.chom.2011.12.003
Dobrindt U Wullt B Svanborg C Asymtomatic bacteriuria as a model to study the coevolution of hosts and Bacteria Pathog 2016 5 1 1 8 10.3390/pathogens5010021
Dobrindt U, Wullt B, Svanborg C (2016) Asymtomatic bacteriuria as a model to study the coevolution of hosts and Bacteria. Pathog 5(1):1–8. 10.3390/pathogens501002110.3390/pathogens5010021
Drage LKL Robson W Mowbray C Ali A Perry JD Walton KE Harding C Pickard R Hall J Aldridge PD Elevated urine IL-10 concentrations associate with Escherichia coli persistence in older patients susceptible to recurrent urinary tract infections’, immunity and ageing Immun Ageing 2019 16 1 1 11 10.1186/s12979-019-0156-9 30679937
Drage LKL, Robson W, Mowbray C, Ali A, Perry JD, Walton KE, Harding C, Pickard R, Hall J, Aldridge PD (2019) Elevated urine IL-10 concentrations associate with Escherichia coli persistence in older patients susceptible to recurrent urinary tract infections’, immunity and ageing. Immun Ageing 16(1):1–11. 10.1186/s12979-019-0156-930679937 10.1186/s12979-019-0156-9
Edgar R Bibi E MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition J Bacteriol 1997 179 7 2274 2280 10.1128/jb.179.7.2274-2280.1997 9079913
Edgar R, Bibi E (1997) MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J Bacteriol 179(7):2274–2280. 10.1128/jb.179.7.2274-2280.19979079913 10.1128/jb.179.7.2274-2280.1997
EUCAST (2023) ‘European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters’, http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_5.0_Breakpoint_Table_01. pdf, pp. 0–77. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_5.0_Breakpoint_Table_01.pdf
Falagas ME Kotsantis IK Vouloumanou EK Rafailidis PI Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials J Infect 2009 58 2 91 102 10.1016/j.jinf.2008.12.009 19195714
Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI (2009) Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect 58(2):91–102. 10.1016/j.jinf.2008.12.00919195714 10.1016/j.jinf.2008.12.009
Finucane TE Urinary tract infection—Requiem for a Heavyweight J Am Geriatr Soc 2017 65 8 1650 1655 10.1111/jgs.14907 28542707
Finucane TE (2017) Urinary tract infection—Requiem for a Heavyweight. J Am Geriatr Soc 65(8):1650–1655. 10.1111/jgs.1490728542707 10.1111/jgs.14907
Florensa AF Kaas RS Clausen PTLC Aytan-Aktug D Aarestrup FM ResFinder – an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes Microb Genom 2022 8 1 1 10 10.1099/mgen.0.000748
Florensa AF, Kaas RS, Clausen PTLC, Aytan-Aktug D, Aarestrup FM (2022) ResFinder – an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes. Microb Genom 8(1):1–10. 10.1099/mgen.0.00074810.1099/mgen.0.000748
Flores V Reasoner S Peard L Abelson B Manuel C Van Horn G Taylor A Adams C Adams M Thomas J Pope J Brock J Morales G Schmitz J Clayton D Hadjifrangiskou M Mp70-11 defining the urinary microbiome of the healthy infant bladder J Urol 2023 209 Supplement 4 2023 10.1097/ju.0000000000003338.11
Flores V, Reasoner S, Peard L, Abelson B, Manuel C, Van Horn G, Taylor A, Adams C, Adams M, Thomas J, Pope J, Brock J, Morales G, Schmitz J, Clayton D, Hadjifrangiskou M (2023) Mp70-11 defining the urinary microbiome of the healthy infant bladder. J Urol 209(Supplement 4):2023. 10.1097/ju.0000000000003338.1110.1097/ju.0000000000003338.11
Forsyth VS Armbruster CE Smith SN Pirani A Springman AC Walters MS Nielubowicz GR Himpsl SD Snitkin ES Mobley HLT Rapid Growth of Uropathogenic Escherichia coli During Human Urinary Tract Infection mBio 2018 10.1128/mBio.00186-18 29511075
Forsyth VS, Armbruster CE, Smith SN, Pirani A, Springman AC, Walters MS, Nielubowicz GR, Himpsl SD, Snitkin ES, Mobley HLT (2018) Rapid Growth of Uropathogenic Escherichia coli During Human Urinary Tract Infection. mBio. 10.1128/mBio.00186-1829511075 10.1128/mBio.00186-18
Frick-Cheng AE Sintsova A Smith SN Krauthammer M Eaton KA Mobley HLT The gene expression profile of uropathogenic escherichia coli in women with uncomplicated urinary tract infections is recapitulated in the mouse model mBio 2020 11 4 1 16 10.1128/mBio.01412-20
Frick-Cheng AE, Sintsova A, Smith SN, Krauthammer M, Eaton KA, Mobley HLT (2020) The gene expression profile of uropathogenic escherichia coli in women with uncomplicated urinary tract infections is recapitulated in the mouse model. mBio 11(4):1–16. 10.1128/mBio.01412-2010.1128/mBio.01412-20
Gágyor I Bleidorn J Kochen MM Schmiemann G Wegscheider K Hummers-Pradier E Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: Randomised controlled trial BMJ 2015 10.1136/bmj.h6544 26698878
Gágyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E (2015) Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: Randomised controlled trial. BMJ. 10.1136/bmj.h654426698878 10.1136/bmj.h6544
Garretto A Miller-Ensminger T Ene A Merchant Z Shah A Gerodias A Biancofiori A Castillo E Canchola S Canchola S Chowdhury T Gandhi N Hamilton S Hatton K Hyder S Krull K Lagios D Lam T Mitchell K Mortensen C Murphy A Richburg J Rokas M Ryclik S Sulit P Szwajnos T Widuch M Willis J Woloszyn M Brassil B Johnson G Mormando R Maskeri L Batrich M Stark N Shapiro JW Hernandez M Banerjee C Wolfe S Putonti C Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms Front Microbiol 2020 10.3389/fmicb.2020.02094 33013764
Garretto A, Miller-Ensminger T, Ene A, Merchant Z, Shah A, Gerodias A, Biancofiori A, Castillo E, Canchola S, Canchola S, Chowdhury T, Gandhi N, Hamilton S, Hatton K, Hyder S, Krull K, Lagios D, Lam T, Mitchell K, Mortensen C, Murphy A, Richburg J, Rokas M, Ryclik S, Sulit P, Szwajnos T, Widuch M, Willis J, Woloszyn M, Brassil B, Johnson G, Mormando R, Maskeri L, Batrich M, Stark N, Shapiro JW, Hernandez M, Banerjee C, Wolfe S, Putonti C (2020) Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms. Front Microbiol. 10.3389/fmicb.2020.0209433013764 10.3389/fmicb.2020.02094
Hansen KH Andreasen MR Pedersen MS Westh H Jelsbak L Schønning K Resistance to piperacillin/tazobactam in Escherichia coli resulting from extensive IS26-associated gene amplification of blaTEM-1 J Antimicrob Chemother 2019 74 11 3179 3183 10.1093/jac/dkz349 31411684
Hansen KH, Andreasen MR, Pedersen MS, Westh H, Jelsbak L, Schønning K (2019) Resistance to piperacillin/tazobactam in Escherichia coli resulting from extensive IS26-associated gene amplification of blaTEM-1. J Antimicrob Chemother 74(11):3179–3183. 10.1093/jac/dkz34931411684 10.1093/jac/dkz349
Hogins J Xuan Z Zimmern PE Reitzer L The distinct transcriptome of virulence-associated phylogenetic group B2 Escherichia coli Microbiol Spectr 2023 10.1128/spectrum.02085-23 37724859
Hogins J, Xuan Z, Zimmern PE, Reitzer L (2023) The distinct transcriptome of virulence-associated phylogenetic group B2 Escherichia coli. Microbiol Spectr. 10.1128/spectrum.02085-2337724859 10.1128/spectrum.02085-23
Horesh G Blackwell GA Tonkin-Hill G Corander J Heinz E Thomson NR A comprehensive and high-quality collection of Escherichia coli genomes and their genes Microb Genom 2021 10.1099/mgen.0.000499 34559043
Horesh G, Blackwell GA, Tonkin-Hill G, Corander J, Heinz E, Thomson NR (2021) A comprehensive and high-quality collection of Escherichia coli genomes and their genes. Microb Genom. 10.1099/mgen.0.00049934559043 10.1099/mgen.0.000499
Hull RA Donovan WH Del Terzo M Stewart C Rogers M Darouiche RO Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli Infect Immun 2002 70 11 6481 6484 10.1128/IAI.70.11.6481-6484.2002 12379733
Hull RA, Donovan WH, Del Terzo M, Stewart C, Rogers M, Darouiche RO (2002) Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect Immun 70(11):6481–6484. 10.1128/IAI.70.11.6481-6484.200212379733 10.1128/IAI.70.11.6481-6484.2002
Joensen KG Tetzschner AMM Iguchi A Aarestrup FM Scheutz F Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data J Clin Microbiol 2015 53 8 2410 2426 10.1128/JCM.00008-15 25972421
Joensen KG, Tetzschner AMM, Iguchi A, Aarestrup FM, Scheutz F (2015) Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. J Clin Microbiol 53(8):2410–2426. 10.1128/JCM.00008-1525972421 10.1128/JCM.00008-15
Johansson MHK Bortolaia V Tansirichaiya S Aarestrup FM Roberts AP Petersen TN Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder J Antimicrob Chemother 2021 76 1 101 109 10.1093/JAC/DKAA390 33009809
Johansson MHK, Bortolaia V, Tansirichaiya S, Aarestrup FM, Roberts AP, Petersen TN (2021) Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder. J Antimicrob Chemother 76(1):101–109. 10.1093/JAC/DKAA39033009809 10.1093/JAC/DKAA390
Jones J Murphy CP Sleator RD Culligan EP The urobiome, urinary tract infections, and the need for alternative therapeutics Microb Pathog 2021 110 105295 10.1016/j.micpath.2021.105295
Jones J, Murphy CP, Sleator RD, Culligan EP (2021) The urobiome, urinary tract infections, and the need for alternative therapeutics. Microb Pathog (110):105295. 10.1016/j.micpath.2021.10529510.1016/j.micpath.2021.105295
Kenneally C Murphy CP Sleator RD Culligan EP The urinary Microbiome and Biological therapeutics: Novel therapies for urinary tract infections Microbiol Res 2022 259 127010 10.1016/j.micres.2022.127010 35338973
Kenneally C, Murphy CP, Sleator RD, Culligan EP (2022) The urinary Microbiome and Biological therapeutics: Novel therapies for urinary tract infections. Microbiol Res 259:127010. 10.1016/j.micres.2022.12701035338973 10.1016/j.micres.2022.127010
Kenneally C Murphy CP Sleator RD Culligan EP Turbidimetric bioassays: a solution to antimicrobial activity detection in asymptomatic bacteriuria isolates against uropathogenic Escherichia coli MicrobiologyOpen 2024 13 3 1 22 10.1002/mbo3.1411
Kenneally C, Murphy CP, Sleator RD, Culligan EP (2024) Turbidimetric bioassays: a solution to antimicrobial activity detection in asymptomatic bacteriuria isolates against uropathogenic Escherichia coli. MicrobiologyOpen 13(3):1–22. 10.1002/mbo3.141110.1002/mbo3.1411
Khasheii B Mahmoodi P Mohammadzadeh A Siderophores: Importance in bacterial pathogenesis and applications in medicine and industry Microbiological Research 2021 Amsterdam Elsevier GmbH 126790
Khasheii B, Mahmoodi P, Mohammadzadeh A (2021) Siderophores: Importance in bacterial pathogenesis and applications in medicine and industry. Microbiological Research, vol 250. Elsevier GmbH, Amsterdam, p 126790
Klein RD Hultgren SJ Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies Nat Rev Microbiol 2020 18 4 211 226 10.1038/s41579-020-0324-0 32071440
Klein RD, Hultgren SJ (2020) Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies. Nat Rev Microbiol 18(4):211–226. 10.1038/s41579-020-0324-032071440 10.1038/s41579-020-0324-0
Klemm P Hancock V Schembri MA Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972 Infect Immun 2007 75 8 3688 3695 10.1128/IAI.01730-06 17502385
Klemm P, Hancock V, Schembri MA (2007) Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect Immun 75(8):3688–3695. 10.1128/IAI.01730-0617502385 10.1128/IAI.01730-06
Kot B Antibiotic resistance among uropathogenic Escherichia coli Pol J Microbiol 2019 68 4 403 415 10.33073/PJM-2019-048 31880885
Kot B (2019) Antibiotic resistance among uropathogenic Escherichia coli. Pol J Microbiol 68(4):403–415. 10.33073/PJM-2019-04831880885 10.33073/PJM-2019-048
Kvesić M Šamanić I Novak A Fredotović Ž Dželalija M Kamenjarin J Goić Barišić I Tonkić M Maravić A Submarine Outfalls of Treated Wastewater Effluents are Sources of Extensively- and Multidrug-Resistant KPC- and OXA-48-Producing Enterobacteriaceae in Coastal Marine Environment Front Microbiol 2022 10.3389/fmicb.2022.858821 35602062
Kvesić M, Šamanić I, Novak A, Fredotović Ž, Dželalija M, Kamenjarin J, Goić Barišić I, Tonkić M, Maravić A (2022) Submarine Outfalls of Treated Wastewater Effluents are Sources of Extensively- and Multidrug-Resistant KPC- and OXA-48-Producing Enterobacteriaceae in Coastal Marine Environment. Front Microbiol. 10.3389/fmicb.2022.85882135602062 10.3389/fmicb.2022.858821
Leihof RF Nielsen KL Frimodt-Møller N Asymptomatic Bacteriuria (ABU) in Elderly: prevalence, virulence, phylogeny, Antibiotic Resistance and complement C3 in urine Microorganisms 2021 9 2 390 10.3390/microorganisms9020390 33672892
Leihof RF, Nielsen KL, Frimodt-Møller N (2021) Asymptomatic Bacteriuria (ABU) in Elderly: prevalence, virulence, phylogeny, Antibiotic Resistance and complement C3 in urine. Microorganisms 9(2):390. 10.3390/microorganisms902039033672892 10.3390/microorganisms9020390
Letunic I Bork P Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation Nucleic Acids Res 2021 49 W1 W293 W296 10.1093/nar/gkab301 33885785
Letunic I, Bork P (2021) Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 49(W1):W293–W296. 10.1093/nar/gkab30133885785 10.1093/nar/gkab301
Lindberg U Hanson LA Jodal U Lidin-Janson G Lincoln K Olling S Asymptomatic Bacteriuria in schoolgirls Acta Paediatr 1975 64 3 432 436 10.1111/j.1651-2227.1975.tb03860.x
Lindberg U, Hanson LA, Jodal U, Lidin-Janson G, Lincoln K, Olling S (1975) Asymptomatic Bacteriuria in schoolgirls. Acta Paediatr 64(3):432–436. 10.1111/j.1651-2227.1975.tb03860.x10.1111/j.1651-2227.1975.tb03860.x
Lynch CT Buttimer C Epping L O’Connor J Walsh N McCarthy C O’Brien D Vaughan C Semmler T Bolton D Coffey A Lucey B Phenotypic and genetic analyses of two Campylobacter fetus isolates from a patient with relapsed prosthetic valve endocarditis Pathog Dis 2021 79 9 1 12 10.1093/femspd/ftab055
Lynch CT, Buttimer C, Epping L, O’Connor J, Walsh N, McCarthy C, O’Brien D, Vaughan C, Semmler T, Bolton D, Coffey A, Lucey B (2021) Phenotypic and genetic analyses of two Campylobacter fetus isolates from a patient with relapsed prosthetic valve endocarditis. Pathog Dis 79(9):1–12. 10.1093/femspd/ftab05510.1093/femspd/ftab055
Magistro G Stief CG The urinary tract Microbiome: the answer to all our Open questions? Eur Urol Focus 2019 5 1 36 38 10.1016/j.euf.2018.06.011 30042043
Magistro G, Stief CG (2019) The urinary tract Microbiome: the answer to all our Open questions? Eur Urol Focus 5(1):36–38. 10.1016/j.euf.2018.06.01130042043 10.1016/j.euf.2018.06.011
Massip C Chagneau CV Boury M Oswald E The synergistic Triad between Microcin, Colibactin, and salmochelin gene clusters in Uropathogenic Escherichia coli Microb Infect 2020 22 3 144 147 10.1016/j.micinf.2020.01.001
Massip C, Chagneau CV, Boury M, Oswald E (2020) The synergistic Triad between Microcin, Colibactin, and salmochelin gene clusters in Uropathogenic Escherichia coli. Microb Infect 22(3):144–147. 10.1016/j.micinf.2020.01.00110.1016/j.micinf.2020.01.001
Morales G Abelson B Reasoner S Miller J Earl AM Hadjifrangiskou M Schmitz J The Role of Mobile Genetic Elements in Virulence Factor Carriage from Symptomatic and Asymptomatic Cases of Escherichia coli Bacteriuria Microbiol Spectr 2023 10.1128/spectrum.04710-22 37966209
Morales G, Abelson B, Reasoner S, Miller J, Earl AM, Hadjifrangiskou M, Schmitz J (2023) The Role of Mobile Genetic Elements in Virulence Factor Carriage from Symptomatic and Asymptomatic Cases of Escherichia coli Bacteriuria. Microbiol Spectr. 10.1128/spectrum.04710-2237966209 10.1128/spectrum.04710-22
Naziri Z Kilegolan JA Moezzi MS Derakhshandeh A Biofilm formation by uropathogenic Escherichia coli: a complicating factor for treatment and recurrence of urinary tract infections J Hosp Infect 2021 117 9 16 10.1016/j.jhin.2021.08.017 34428502
Naziri Z, Kilegolan JA, Moezzi MS, Derakhshandeh A (2021) Biofilm formation by uropathogenic Escherichia coli: a complicating factor for treatment and recurrence of urinary tract infections. J Hosp Infect 117:9–16. 10.1016/j.jhin.2021.08.01734428502 10.1016/j.jhin.2021.08.017
Nicolle LE The paradigm shift to non-treatment of asymptomatic bacteriuria Pathog 2016 5 2 2 7 10.3390/pathogens5020038
Nicolle LE (2016) The paradigm shift to non-treatment of asymptomatic bacteriuria. Pathog 5(2):2–7. 10.3390/pathogens502003810.3390/pathogens5020038
Nicolle LE Bradley S Colgan R Rice JC Schaeffer A Hooton TM Erratum: Infectious Diseases Society of America Guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults Clin Infect Dis 2005 40 10 1556 10.1086/430607
Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM (2005) Erratum: Infectious Diseases Society of America Guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40(10):1556. 10.1086/43060710.1086/430607
Nüesch-Inderbinen MT Baschera M Zurfluh K Hächler H Nüesch H Stephan R Clonal diversity, virulence potential and antimicrobial resistance of Escherichia coli causing community acquired urinary tract infection in Switzerland Front Microbiol 2017 10.3389/fmicb.2017.02334 29250044
Nüesch-Inderbinen MT, Baschera M, Zurfluh K, Hächler H, Nüesch H, Stephan R (2017) Clonal diversity, virulence potential and antimicrobial resistance of Escherichia coli causing community acquired urinary tract infection in Switzerland. Front Microbiol. 10.3389/fmicb.2017.0233429250044 10.3389/fmicb.2017.02334
O’Toole GA Microtiter dish biofilm formation assay J Vis Exp 2010 47 10 11 10.3791/2437
O’Toole GA (2010) Microtiter dish biofilm formation assay. J Vis Exp 47:10–11. 10.3791/243710.3791/2437
Packiriswamy N Gandy J Smith SN Mobley HLT Sordillo LM Subashchandrabose S Distinct Signature of Oxylipid Mediators of Inflammation during Infection and Asymptomatic Colonization by E. coli in the Urinary Bladder Mediators Inflamm 2017 10.1155/2017/4207928 29445256
Packiriswamy N, Gandy J, Smith SN, Mobley HLT, Sordillo LM, Subashchandrabose S (2017) Distinct Signature of Oxylipid Mediators of Inflammation during Infection and Asymptomatic Colonization by E. coli in the Urinary Bladder. Mediators Inflamm. 10.1155/2017/420792829445256 10.1155/2017/4207928
Page AJ Cummins CA Hunt M Wong VK Reuter S Holden MTG Fookes M Falush D Keane JA Parkhill J Roary: Rapid large-scale prokaryote pan genome analysis Bioinform 2015 31 22 3691 3693 10.1093/bioinformatics/btv421
Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, Fookes M, Falush D, Keane JA, Parkhill J (2015) Roary: Rapid large-scale prokaryote pan genome analysis. Bioinform 31(22):3691–3693. 10.1093/bioinformatics/btv42110.1093/bioinformatics/btv421
Price MN Dehal PS Arkin AP FastTree 2 - Approximately maximum-likelihood trees for large alignments PLoS ONE 2010 10.1371/journal.pone.0009490 21170387
Price MN, Dehal PS, Arkin AP (2010) FastTree 2 - Approximately maximum-likelihood trees for large alignments. PLoS ONE. 10.1371/journal.pone.000949021170387 10.1371/journal.pone.0009490
Price TK Hilt EE Thomas-White K Mueller ER Wolfe AJ Brubaker L The urobiome of continent adult women: a cross-sectional study BJOG 2020 127 2 193 201 10.1111/1471-0528.15920 31469215
Price TK, Hilt EE, Thomas-White K, Mueller ER, Wolfe AJ, Brubaker L (2020) The urobiome of continent adult women: a cross-sectional study. BJOG 127(2):193–201. 10.1111/1471-0528.1592031469215 10.1111/1471-0528.15920
Rasko DA Rosovitz MJ Myers GSA Mongodin EF Fricke WF Gajer P Crabtree J Sebaihia M Thomson NR Chaudhuri R Henderson IR Sperandio V Ravel J The pangenome structure of Escherichia coli: comparative genomic analysis of E. Coli commensal and pathogenic isolates J Bacteriol 2008 190 20 6881 6893 10.1128/JB.00619-08 18676672
Rasko DA, Rosovitz MJ, Myers GSA, Mongodin EF, Fricke WF, Gajer P, Crabtree J, Sebaihia M, Thomson NR, Chaudhuri R, Henderson IR, Sperandio V, Ravel J (2008) The pangenome structure of Escherichia coli: comparative genomic analysis of E. Coli commensal and pathogenic isolates. J Bacteriol 190(20):6881–6893. 10.1128/JB.00619-0818676672 10.1128/JB.00619-08
Reitzer L Zimmern P Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition Clin Microbiol Rev 2020 10.1128/CMR.00101-19
Reitzer L, Zimmern P (2020) Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition. Clin Microbiol Rev. 10.1128/CMR.00101-1910.1128/CMR.00101-19
Roer L Johannesen TB Hansen F Stegger M Tchesnokova V Sokurenko E Garibay N Allesøe R Thomsen MCF Lund O Hasman H Hammerum AM CHTyper, a web tool for subtyping of extraintestinal pathogenic Escherichia coli based on the fumC and fimH alleles J Clin Microbiol 2018 56 4 1 3 10.1128/JCM.00063-18
Roer L, Johannesen TB, Hansen F, Stegger M, Tchesnokova V, Sokurenko E, Garibay N, Allesøe R, Thomsen MCF, Lund O, Hasman H, Hammerum AM (2018) CHTyper, a web tool for subtyping of extraintestinal pathogenic Escherichia coli based on the fumC and fimH alleles. J Clin Microbiol 56(4):1–3. 10.1128/JCM.00063-1810.1128/JCM.00063-18
Roos V Nielsen EM Klemm P Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition FEMS Microbiol Lett 2006 262 1 22 30 10.1111/j.1574-6968.2006.00355.x 16907735
Roos V, Nielsen EM, Klemm P (2006) Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett 262(1):22–30. 10.1111/j.1574-6968.2006.00355.x16907735 10.1111/j.1574-6968.2006.00355.x
Rudick CN Taylor AK Yaggie RE Schaeffer AJ Klumpp DJ Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI PLoS ONE 2014 9 11 1 9 10.1371/journal.pone.0109321
Rudick CN, Taylor AK, Yaggie RE, Schaeffer AJ, Klumpp DJ (2014) Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI. PLoS ONE 9(11):1–9. 10.1371/journal.pone.010932110.1371/journal.pone.0109321
Saldaña Z Erdem AL Schüller S Okeke IN Lucas M Sivananthan A Phillips AD Kaper JB Puente JL Girón JA The Escherichia coli common pilus and the bundle-forming pilus act in concert during the formation of localized adherence by enteropathogenic E. Coli J Bacteriol 2009 191 11 3451 3461 10.1128/JB.01539-08 19218393
Saldaña Z, Erdem AL, Schüller S, Okeke IN, Lucas M, Sivananthan A, Phillips AD, Kaper JB, Puente JL, Girón JA (2009) The Escherichia coli common pilus and the bundle-forming pilus act in concert during the formation of localized adherence by enteropathogenic E. Coli. J Bacteriol 191(11):3451–3461. 10.1128/JB.01539-0819218393 10.1128/JB.01539-08
Saldaña Z De La Cruz MA Carrillo-Casas EM Durán L Zhang Y Hernández-Castro R Puente JL Daaka Y Girón JA Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium PLoS ONE 2014 10.1371/journal.pone.0101200 25036370
Saldaña Z, De La Cruz MA, Carrillo-Casas EM, Durán L, Zhang Y, Hernández-Castro R, Puente JL, Daaka Y, Girón JA (2014) Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium. PLoS ONE. 10.1371/journal.pone.010120025036370 10.1371/journal.pone.0101200
Schulz M Gaitanoglou V Mantel O Hövelmann Y Hübner F Dobrindt U Humpf HU Metabolomics study on pathogenic and non-pathogenic E. Coli with closely related genomes with a focus on yersiniabactin and its known and novel derivatives Metabolites 2020 10 6 1 36 10.3390/metabo10060221
Schulz M, Gaitanoglou V, Mantel O, Hövelmann Y, Hübner F, Dobrindt U, Humpf HU (2020) Metabolomics study on pathogenic and non-pathogenic E. Coli with closely related genomes with a focus on yersiniabactin and its known and novel derivatives. Metabolites 10(6):1–36. 10.3390/metabo1006022110.3390/metabo10060221
Seemann T Prokka: Rapid prokaryotic genome annotation Bioinform 2014 30 14 2068 2069 10.1093/bioinformatics/btu153
Seemann T (2014) Prokka: Rapid prokaryotic genome annotation. Bioinform 30(14):2068–2069. 10.1093/bioinformatics/btu15310.1093/bioinformatics/btu153
Spaulding CN Klein RD Ruer S Kau AL Schreiber HL Cusumano ZT Dodson KW Pinkner JS Fremont DH Janetka JW Remaut H Gordon JI Hultgren SJ Selective depletion of uropathogenic E. Coli from the gut by a FimH antagonist Nature 2017 546 7659 528 532 10.1038/nature22972 28614296
Spaulding CN, Klein RD, Ruer S, Kau AL, Schreiber HL, Cusumano ZT, Dodson KW, Pinkner JS, Fremont DH, Janetka JW, Remaut H, Gordon JI, Hultgren SJ (2017) Selective depletion of uropathogenic E. Coli from the gut by a FimH antagonist. Nature 546(7659):528–532. 10.1038/nature2297228614296 10.1038/nature22972
Stork C Kovács B Rózsai B Putze J Kiel M Dorn Á Kovács J Melegh S Leimbach A Kovács T Schneider G Kerényi M Emödy L Dobrindt U Characterization of asymptomatic Bacteriuria Escherichia coli isolates in search of alternative strains for efficient bacterial interference against Uropathogens Front Microbiol 2018 9 214 1 18 10.3389/fmicb.2018.00214 29403456
Stork C, Kovács B, Rózsai B, Putze J, Kiel M, Dorn Á, Kovács J, Melegh S, Leimbach A, Kovács T, Schneider G, Kerényi M, Emödy L, Dobrindt U (2018) Characterization of asymptomatic Bacteriuria Escherichia coli isolates in search of alternative strains for efficient bacterial interference against Uropathogens. Front Microbiol 9(214):1–18. 10.3389/fmicb.2018.0021429403456 10.3389/fmicb.2018.00214
Suarez SA Martiny AC Gene Amplification Uncovers Large Previously Unrecognized Cryptic Antibiotic Resistance Potential in E. coli Microbiol Spectr 2021 10.1128/spectrum.00289-21 34756069
Suarez SA, Martiny AC (2021) Gene Amplification Uncovers Large Previously Unrecognized Cryptic Antibiotic Resistance Potential in E. coli. Microbiol Spectr. 10.1128/spectrum.00289-2134756069 10.1128/spectrum.00289-21
Tantoso E Eisenhaber B Kirsch M Shitov V Zhao Z Eisenhaber F To kill or to be killed: pangenome analysis of Escherichia coli strains reveals a tailocin specific for pandemic ST131 BMC Biol 2022 20 1 1 26 10.1186/s12915-022-01347-7 34983491
Tantoso E, Eisenhaber B, Kirsch M, Shitov V, Zhao Z, Eisenhaber F (2022) To kill or to be killed: pangenome analysis of Escherichia coli strains reveals a tailocin specific for pandemic ST131. BMC Biol 20(1):1–26. 10.1186/s12915-022-01347-734983491 10.1186/s12915-022-01347-7
Tarlton NJ Moritz C Adams-Sapper S Riley LW Genotypic analysis of uropathogenic Escherichia coli to understand factors that impact the prevalence of β-lactam-resistant urinary tract infections in a community J Glob Antimicrob Resist 2019 19 3 173 180 10.1016/j.jgar.2019.03.002 30872040
Tarlton NJ, Moritz C, Adams-Sapper S, Riley LW (2019) Genotypic analysis of uropathogenic Escherichia coli to understand factors that impact the prevalence of β-lactam-resistant urinary tract infections in a community. J Glob Antimicrob Resist 19(3):173–180. 10.1016/j.jgar.2019.03.00230872040 10.1016/j.jgar.2019.03.002
Terlizzi ME Gribaudo G Maffei ME UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies Front Microbiol 2017 8 AUG 2 12 10.3389/fmicb.2017.01566 28149293
Terlizzi ME, Gribaudo G, Maffei ME (2017) UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol 8(AUG):2–12. 10.3389/fmicb.2017.0156628149293 10.3389/fmicb.2017.01566
Vagios S Hesham H Mitchell C Understanding the potential of Lactobacilli in recurrent UTI Prevention Microb Pathog 2020 148 104544 10.1016/j.micpath.2020.104544 33010368
Vagios S, Hesham H, Mitchell C (2020) Understanding the potential of Lactobacilli in recurrent UTI Prevention. Microb Pathog 148:104544. 10.1016/j.micpath.2020.10454433010368 10.1016/j.micpath.2020.104544
Valdebenito M Crumbliss AL Winkelmann G Hantke K Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917 Int J Med Microbiol 2006 296 8 513 520 10.1016/j.ijmm.2006.06.003 17008127
Valdebenito M, Crumbliss AL, Winkelmann G, Hantke K (2006) Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int J Med Microbiol 296(8):513–520. 10.1016/j.ijmm.2006.06.00317008127 10.1016/j.ijmm.2006.06.003
Wang C Li Q Lv J Sun X Cao Y Yu K Miao C Zhang ZS Yao Z Wang Q Alpha-hemolysin of uropathogenic Escherichia coli induces GM-CSF-mediated acute kidney injury Mucosal Immunol 2020 13 1 22 33 10.1038/s41385-019-0225-6 31719643
Wang C, Li Q, Lv J, Sun X, Cao Y, Yu K, Miao C, Zhang ZS, Yao Z, Wang Q (2020) Alpha-hemolysin of uropathogenic Escherichia coli induces GM-CSF-mediated acute kidney injury. Mucosal Immunol 13(1):22–33. 10.1038/s41385-019-0225-631719643 10.1038/s41385-019-0225-6
Waters NR Abram F Brennan F Holmes A Pritchard L Easy phylotyping of Escherichia coli via the EzClermont web app and command-line tool Access Microbiol 2020 10.1099/acmi.0.000143 33195978
Waters NR, Abram F, Brennan F, Holmes A, Pritchard L (2020) Easy phylotyping of Escherichia coli via the EzClermont web app and command-line tool. Access Microbiol. 10.1099/acmi.0.00014333195978 10.1099/acmi.0.000143
Watts RE Hancock V Ong CLY Vejborg RM Mabbett AN Totsika M Looke DF Nimmo GR Klemm P Schembri MA Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties J Clin Microbiol 2010 48 7 2449 2458 10.1128/JCM.01611-09 20444967
Watts RE, Hancock V, Ong CLY, Vejborg RM, Mabbett AN, Totsika M, Looke DF, Nimmo GR, Klemm P, Schembri MA (2010) Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties. J Clin Microbiol 48(7):2449–2458. 10.1128/JCM.01611-0920444967 10.1128/JCM.01611-09
Whelan FJ Rusilowicz M McInerney JO Coinfinder: Detecting significant associations and dissociations in pangenomes Microb Genom 2020 10.1099/mgen.0.000338 32100706
Whelan FJ, Rusilowicz M, McInerney JO (2020) Coinfinder: Detecting significant associations and dissociations in pangenomes. Microb Genom. 10.1099/mgen.0.00033832100706 10.1099/mgen.0.000338
Whelan S O’Grady MC Corcoran D Finn K Lucey B Uropathogenic Escherichia coli Biofilm-Forming capabilities are not predictable from clinical details or from colonial morphology Diseases 2020 8 2 11 10.3390/diseases8020011 32365789
Whelan S, O’Grady MC, Corcoran D, Finn K, Lucey B (2020b) Uropathogenic Escherichia coli Biofilm-Forming capabilities are not predictable from clinical details or from colonial morphology. Diseases 8(2):11. 10.3390/diseases802001132365789 10.3390/diseases8020011
Yamaji R Rubin J Thys E Friedman CR Riley LW Persistent pandemic lineages of uropathogenic Escherichia coli in a college community from 1999 to 2017 J Clin Microbiol 2018 56 4 1 10 10.1128/JCM.01834-17
Yamaji R, Rubin J, Thys E, Friedman CR, Riley LW (2018) Persistent pandemic lineages of uropathogenic Escherichia coli in a college community from 1999 to 2017. J Clin Microbiol 56(4):1–10. 10.1128/JCM.01834-1710.1128/JCM.01834-17
Yardeni EH Mishra S Stein RA Bibi E Mchaourab HS The Multidrug Transporter MdfA deviates from the Canonical Model of Alternating Access of MFS transporters J Mol Biol 2020 432 20 5665 5680 10.1016/j.jmb.2020.08.017 32860775
Yardeni EH, Mishra S, Stein RA, Bibi E, Mchaourab HS (2020) The Multidrug Transporter MdfA deviates from the Canonical Model of Alternating Access of MFS transporters. J Mol Biol 432(20):5665–5680. 10.1016/j.jmb.2020.08.01732860775 10.1016/j.jmb.2020.08.017
Zdziarski J Svanborg C Wullt B Hacker J Dobrindt U Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun 2008 76 2 695 703 10.1128/IAI.01215-07 18039831
Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U (2008) Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun 76(2):695–703. 10.1128/IAI.01215-0718039831 10.1128/IAI.01215-07
Zdziarski J Brzuszkiewicz E Wullt B Liesegang H Biran D Voigt B Grönberg-Hernandez J Ragnarsdottir B Hecker M Ron EZ Daniel R Gottschalk G Hacker J Svanborg C Dobrindt U Host imprints on bacterial genomes-rapid, divergent evolution in individual patients PLoS Pathog 2010 6 8 95 96 10.1371/journal.ppat.1001078
Zdziarski J, Brzuszkiewicz E, Wullt B, Liesegang H, Biran D, Voigt B, Grönberg-Hernandez J, Ragnarsdottir B, Hecker M, Ron EZ, Daniel R, Gottschalk G, Hacker J, Svanborg C, Dobrindt U (2010) Host imprints on bacterial genomes-rapid, divergent evolution in individual patients. PLoS Pathog 6(8):95–96. 10.1371/journal.ppat.100107810.1371/journal.ppat.1001078
Zhou Z Alikhan NF Mohamed K Fan Y Achtman M The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity Genome Res 2020 30 1 138 152 10.1101/gr.251678.119 31809257
Zhou Z, Alikhan NF, Mohamed K, Fan Y, Achtman M (2020) The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res 30(1):138–152. 10.1101/gr.251678.11931809257 10.1101/gr.251678.119
